114 related articles for article (PubMed ID: 15277992)
1. Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation.
Surowiak P; Paluchowski P; Dziegiel P; Wysocka T; Wojnar A; Spaczyński M; Zabel M
Med Sci Monit; 2004 Aug; 10(8):BR300-5. PubMed ID: 15277992
[TBL] [Abstract][Full Text] [Related]
2. The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel.
Surowiak P; Kaplenko I; Spaczyński M; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):493-5. PubMed ID: 14655150
[TBL] [Abstract][Full Text] [Related]
3. Role of metallothionein expression in non-small cell lung carcinomas.
Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
[TBL] [Abstract][Full Text] [Related]
4. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
Werynska B; Pula B; Muszczynska-Bernhard B; Piotrowska A; Jethon A; Podhorska-Okolow M; Dziegiel P; Jankowska R
Anticancer Res; 2011 Sep; 31(9):2833-9. PubMed ID: 21868526
[TBL] [Abstract][Full Text] [Related]
5. Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.
Zasławski R; Surowiak P; Paluchowski P; Dziegiel P; Maciejczyk A; Pudełko M; Wojnar A; Zabel M
Folia Morphol (Warsz); 2005 Feb; 64(1):9-15. PubMed ID: 15832264
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
[TBL] [Abstract][Full Text] [Related]
7. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis.
Zhang R; Zhang H; Wei H; Luo X
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
9. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
11. Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma.
Wojnar A; Pula B; Piotrowska A; Jethon A; Kujawa K; Kobierzycki C; Rys J; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2011 Sep; 31(9):3027-33. PubMed ID: 21868554
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers.
Surowiak P; Paluchowski P; Wysocka T; Wojnar A; Zabel M
Pathol Oncol Res; 2004; 10(4):207-11. PubMed ID: 15619641
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein expression in invasive and in situ breast carcinomas.
Gallicchio LM; Flaws JA; Fowler BA; Ioffe OB
Cancer Detect Prev; 2005; 29(4):332-7. PubMed ID: 16122884
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of apoptosis, proliferation intensity and metallothionein (MT) expression in comparison with selected clinicopathological variables in primary adenocarcinomas of the large intestine.
Dumańska M; Dziegiel P; Sopel M; Wojnar A; Zabel M
Folia Morphol (Warsz); 2004 Feb; 63(1):107-10. PubMed ID: 15039913
[TBL] [Abstract][Full Text] [Related]
15. Intensity of apoptosis as related to the expression of metallothionein (MT), caspase-3 (cas-3) and Ki-67 antigen and the survival time of patients with primary colorectal adenocarcinomas.
Dziegiel P; Dumańska M; Forgacz J; Wojna A; Zabel M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():5-7. PubMed ID: 15638357
[TBL] [Abstract][Full Text] [Related]
16. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity.
Popiela TJ; Rudnicka-Sosin L; Dutsch-Wicherek M; Klimek M; Basta P; Galazka K; Wicherek L
Neuro Endocrinol Lett; 2006 Dec; 27(6):786-94. PubMed ID: 17187007
[TBL] [Abstract][Full Text] [Related]
17. Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers.
Gomulkiewicz A; Podhorska-Okolow M; Szulc R; Smorag Z; Wojnar A; Zabel M; Dziegiel P
Folia Histochem Cytobiol; 2010 Jan; 48(2):242-8. PubMed ID: 20675281
[TBL] [Abstract][Full Text] [Related]
18. Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.
Surowiak P; Murawa D; Materna V; Maciejczyk A; Pudelko M; Ciesla S; Breborowicz J; Murawa P; Zabel M; Dietel M; Lage H
Anticancer Res; 2007; 27(4C):2917-24. PubMed ID: 17695471
[TBL] [Abstract][Full Text] [Related]
19. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
20. Proliferation measurement in breast cancer by two different methods.
Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J
Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
